In Silico Design and Validation of CRISPR-Cas13a System as a Potential Antiviral for SARS-CoV-2 in Indonesia. nuscientech [Internet]. 2022 Mar. 30 [cited 2025 Apr. 24];:44-51. Available from: https://nstproceeding.com/index.php/nuscientech/article/view/628